Skip to main content
. 2023 Jun 1;43(8):1453–1458. doi: 10.1007/s00296-023-05335-0

Table 2.

Results of mixed linear regression analyses with clinic/hospital as random variable and duration from symptom onset to first contact with a rheumatologist as independent variable

SLE estimates (95% CI) Primary Sjögren’s syndrome estimates (95% CI) Systemic sclerosis estimates (95% CI) Myositis estimates (95% CI) Undifferentiated connective tissue disease estimates (95% CI)
Age (per 10 years) 0.38 (0.36; 0.41) 0.46 (0.43; 0.49) 0.41 (0.38; 0.44) 0.19 (0.15; 0.24) 0.36 (0.34; 0.39)
Gender (female) 1.7 (1.7; 1.8) 2.5 (2.4; 2.7) 2.6 (2.4; 2.8) 1.2 (1; 1.5) 1.9 (1.8; 2)
Gender (male) 1.8 (1.5; 2) 2.3 (1.8; 2.9) 1.5 (1.1; 1.8) 1 (0.6; 1.4) 1.5 (1.2; 1.7)
Disease severity*
Asymptomatic (1) 1.1 (0.8; 1.5) 1.4 (0.6; 2.2) 0.8 (− 0.3; 2) 0.1 (− 0.9; 1.1) 1 (0.6; 1.4)
Mild (2) 1.1 (0.9; 1.3) 1.7 (1.4; 2) 1.5 (1.2; 1.8) 0.2 (− 0.3; 0.7) 1.2 (0.9; 1.4)
Moderate (3) 0.9 (0.7; 1.1) 1.6 (1.2; 1.9) 1.6 (1.3; 1.9) 0.3 (− 0.1; 0.7) 0.9 (0.6; 1.1)
Severe (4) 0.9 (0.6; 1.2) 1.8 (1.2; 2.5) 1.1 (0.6; 1.5) 0.3 (− 0.3; 0.9) 0.9 (0.5; 1.4)
Very severe (5) 1.4 (0.7; 2) 1.5 (− 1.4; 4.4) 1.7 (0.8; 2.5) 1.2 (0; 2.4) 0.2 (− 1.1; 1.5)
Education (year) − 0.007 (− 0.029; 0.014) 0.041 (0.017; 0.064) 0.032 (0.007; 0.057) − 0.061 (− 0.089; − 0.032) − 0.004 (− 0.025; 0.018)

SLE systemic lupus erythematosus

*Model adjusted for age and sex